138 related articles for article (PubMed ID: 22861386)
1. Serum and CSF soluble CD26 and CD30 concentrations in healthy pediatric surgical outpatients.
Delezuch W; Marttinen P; Kokki H; Heikkinen M; Vanamo K; Pulkki K; Matinlauri I
Tissue Antigens; 2012 Oct; 80(4):368-75. PubMed ID: 22861386
[TBL] [Abstract][Full Text] [Related]
2. Association of serum-soluble CD26 and CD30 levels with asthma, lung function and bronchial hyper-responsiveness at school age.
Remes ST; Delezuch W; Pulkki K; Pekkanen J; Korppi M; Matinlauri IH
Acta Paediatr; 2011 Sep; 100(9):e106-11. PubMed ID: 21401715
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD26 and CD30 levels in patients with common variable immunodeficiency.
Mahmoudi M; Hedayat M; Aghamohammadi A; Rezaei N
J Investig Allergol Clin Immunol; 2013; 23(2):120-4. PubMed ID: 23654079
[TBL] [Abstract][Full Text] [Related]
4. Plasma sCD26 and sCD30 levels in cutaneous leishmaniasis.
Jafari-Shakib R; Shokrgozar MA; Nassiri-Kashani M; Malakafzali B; Nikbin B; Khamesipour A
Acta Trop; 2009 Jan; 109(1):61-3. PubMed ID: 18983807
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD26/CD30 levels in visceral leishmaniasis: markers of disease activity.
Ajdary S; Riazi-Rad F; Jafari-Shakib R; Mohebbali M
Clin Exp Immunol; 2006 Jul; 145(1):44-7. PubMed ID: 16792672
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26.
Katoh N; Hirano S; Suehiro M; Ikenaga K; Yamashita T; Sugawara N; Yasuno H
Clin Exp Immunol; 2000 Aug; 121(2):187-92. PubMed ID: 10931130
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble CD26 and CD30 in patients on hemodialysis.
Nakao K; Nagake Y; Okamoto A; Ichikawa H; Yamamura M; Makino H
Nephron; 2002 Jun; 91(2):215-21. PubMed ID: 12053056
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD26 and CD30 levels in patients with anthroponotic cutaneous leishmaniasis.
Ajdary S; Jafari-Shakib R; Riazi-Rad F; Khamesipour A
J Infect; 2007 Jul; 55(1):75-8. PubMed ID: 17241668
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age.
Heshmat NM; El-Hadidi ES
Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784
[TBL] [Abstract][Full Text] [Related]
10. Changes in plasma soluble CD26 and CD30 during pregnancy: markers of Th1/Th2 balance?
Hoshimoto K; Ohta N; Ohkura T; Inaba N
Gynecol Obstet Invest; 2000; 50(4):260-3. PubMed ID: 11093050
[TBL] [Abstract][Full Text] [Related]
11. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels.
Miyagaki T; Sugaya M; Suga H; Morimura S; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):19-24. PubMed ID: 22077186
[TBL] [Abstract][Full Text] [Related]
12. Age-dependent changes of serum soluble CD30 concentration in children.
Chrul S; Polakowska E
Pediatr Transplant; 2011 Aug; 15(5):515-8. PubMed ID: 21672104
[TBL] [Abstract][Full Text] [Related]
13. Levels of Soluble CD30 and CD26 and Their Clinical Significance in Patients with Primary Immune Thrombocytopenia.
Wang H; Gu X; Li H; Yin L; Tao W; Yu J; Zhou Q; Mu H; Shen Y; Yao J; Liu L; Bi H; Yang R; Zhou Z
Biomed Res Int; 2020; 2020():1279371. PubMed ID: 32337220
[TBL] [Abstract][Full Text] [Related]
14. Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus.
Kobayashi H; Hosono O; Mimori T; Kawasaki H; Dang NH; Tanaka H; Morimoto C
J Rheumatol; 2002 Sep; 29(9):1858-66. PubMed ID: 12233879
[TBL] [Abstract][Full Text] [Related]
15. Plasma soluble CD30 level correlates negatively with age in children.
Chen JY; Fu LS; Chu JJ; Chen HC; Chi CS
J Microbiol Immunol Infect; 2007 Apr; 40(2):168-72. PubMed ID: 17446967
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD26/30 levels before and after treatment with interferon-alpha and ribavirin combination therapy in a pediatric hepatitis C patient.
Liao YR; Yen CP; Lin CC; Fu LS; Chiu CC; Chi CS
J Microbiol Immunol Infect; 2004 Feb; 37(1):67-70. PubMed ID: 15060691
[TBL] [Abstract][Full Text] [Related]
17. Impaired expression of CD26 compromises T-cell recruitment in human visceral leishmaniasis.
Rai AK; Thakur CP; Kumar P; Mitra DK
Eur J Immunol; 2012 Oct; 42(10):2782-91. PubMed ID: 22806538
[TBL] [Abstract][Full Text] [Related]
18. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition.
Chilosi M; Facchetti F; Notarangelo LD; Romagnani S; Del Prete G; Almerigogna F; De Carli M; Pizzolo G
Eur J Immunol; 1996 Feb; 26(2):329-34. PubMed ID: 8617299
[TBL] [Abstract][Full Text] [Related]
19. Do the initial serum level changes of sCD26 have ability to predict successful treatment with IFN-α among naïve chronic hepatitis B patients?
Alavi-Moghaddam M; Alavian SM; Aalaei-Andabili SH; Eslami-Far A
Vaccine; 2011 Nov; 29(48):9093-7. PubMed ID: 21893143
[TBL] [Abstract][Full Text] [Related]
20. Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides.
Schönermarck U; Csernok E; Trabandt A; Hansen H; Gross WL
Clin Exp Rheumatol; 2000; 18(4):457-63. PubMed ID: 10949720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
